February 3, 2022, Western District of New York – RDC Liquidating Trust, through its trustee Advisory Trust Group, LLC, for the bankruptcy estate of Debtor Rochester Drug Co-Operative, Inc. brings lawsuits for avoidance and recovery of alleged preferential transfers and objection to claims under Sections 547, 548 and 502 of the Bankruptcy code against seventy-two (72) defendants.
RDC seeks to recover over $59.4 million from the lawsuits filed so far. The most significant cases in the group include:
| Adversary Proceeding Number | Defendants | Amount of Claim ($) |
| 22-02020 | Jom Pharmaceutical Services, Inc. & Janssen Pharmaceutica, L.P. | 6,012,577.8 |
| 22-02012 | Eli Lilly and Company | 5,022,889.2 |
| 22-02059 | GlaxoSmithKline, LLC | 4,895,887.0 |
| 22-02001 | Abbvie US LLC | 3,852,998.7 |
| 22-02065 | Bristol-Myers Squibb Company | 3,213,469.0 |
| 22-02008 | Astrazeneca LP | 2,564,813.3 |
| 22-02055 | Sanofi-Aventis U.S. LLC | 2,273.775.7 |
| 22-02063 | Bausch Health US, LLC | 2,106,600.7 |
| 22-02017 | Horizon Medicines, LLC | 1,903,101.7 |
The case is In re Rochester Drug Cooperative, Inc., jointly administered under Case No. Case No. 20-20230 (PRW) in the United States Bankruptcy Code for Western District of New York. Honorable Bankruptcy Judge Warren is overseeing the Debtor’s bankruptcy cases. The law firm of Pachulski Stang Ziehl & Jones LLP is representing the Trust.
(53)